Infusion Pump Market Report 2026

Infusion Pump Market Overview

• Infusion Pump market size has reached to $15.73 billion in 2025 • Expected to grow to $25.01 billion in 2030 at a compound annual growth rate (CAGR) of 9.8% • Growth Driver: Rising Prevalence Of Chronic Diseases To Drive Market Growth • Market Trend: Advanced Infusion Management Software Transforming The Market • North America was the largest region in 2025.

What Is Covered Under Infusion Pump Market?

An infusion pump refers to a medical device that is used to deliver fluids, such as medications or nutrients, into a patient's bloodstream in a controlled manner. Infusion pumps work by using a pump mechanism to control the rate and volume of fluid delivered to the patient. The main product types of infusion pumps are accessories and consumables, and devices. Accessories and consumables refer to additional components that can be used to enhance the performance or functionality of the medical device. The various pump types are volumetric infusion pumps, insulin pumps, enteral infusion pumps, syringe infusion pumps, ambulatory infusion pumps, PCA pumps, and implantable infusion pumps with technologies that include traditional infusion pumps, and specialty infusion pumps. The various applications are chemotherapy or oncology, diabetes management, gastroenterology, pain management or analgesia, pediatrics or neonatology, hematology, and others used in hospitals, ambulatory care settings, specialty clinics, and home care settings.

What Is The Infusion Pump Market Growth Forecast?

The infusion pump market size is expected to see strong growth in the next few years. It will grow to $25.01 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing demand for home infusion therapy, rising adoption of connected healthcare devices, expansion of chronic disease management programs, growing focus on interoperability with hospital systems, increasing investments in smart hospital infrastructure. Major trends in the forecast period include increasing adoption of smart infusion pumps, rising use of ambulatory and home-based infusion devices, growing integration of dose error reduction systems, expansion of wireless connectivity in infusion systems, enhanced focus on patient safety and accuracy.

Global Infusion Pump Market Segmentation

1) By Product: Accessories And Consumables, Devices 2) By Technology: Traditional Infusion Pumps, Specialty Infusion Pumps 3) By Application: Chemotherapy Or Oncology, Diabetes Management, Gastroenterology, Pain Management Or Analgesia, Pediatrics Or Neonatology, Hematology, Other Applications 4) By End User: Hospitals, Ambulatory Care Settings, Specialty Clinics, Home Care Settings Subsegments: 1) By Accessories And Consumables: Infusion Sets, IV Catheters, Syringes, Safety Needles, Tubing 2) By Devices: Volumetric Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, PCA (Patient-Controlled Analgesia) Pumps, Insulin Pumps, Enteral Infusion Pumps

What Is The Driver Of The Infusion Pump Market?

The rise in the prevalence of chronic diseases is expected to propel the growth of the infusion pump market going forward. Chronic diseases refer to noncommunicable diseases (NCDs), which are long-term health conditions and often progress slowly over an extended period. The rise in the prevalence of chronic diseases, such as cancer and diabetes, is mostly driven by changing lifestyles, lack of physical activities, decreasing quality of life, and poor eating habits. Infusion pumps are used to treat some of these chronic diseases by providing accurate dosing, precise fluid delivery, and customized treatments. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, there would be 142.66 million people with chronic diseases worldwide by the year 2050, up from 71.522 million in 2020. Also, the International Diabetes Federation, an organization of over 230 national diabetes associations in more than 160 countries and territories, projected that, there would be 643 million diabetics worldwide by 2030 and 783 million by 2045. Therefore, a rise in the prevalence of chronic diseases will fuel the infusion pump industry growth.

Key Players In The Global Infusion Pump Market

Major companies operating in the infusion pump market are Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi AG, Smiths Medical Inc., Medtronic plc, Moog Inc., Terumo Corporation, Insulet Corporation, Boston Scientific Corporation, Tandem Diabetes Care Inc., InfuTronix Solutions LLC, Micrel Medical Devices SA, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Mindray Medical International Limited, Caesarea Medical Electronics Ltd., Hospitech Respiration Ltd., IRadimed Corporation, Ivenix Inc., Sooil Development Co. Ltd., ZOLL Medical Corporation, Zyno Medical LLC

Global Infusion Pump Market Trends and Insights

Major companies operating in the infusion pump market are developing infusion management software to gain a competitive edge in the market. Infusion management software refers to specialized computer programs designed to oversee and optimize the administration of fluids, medications, and other therapeutic agents through infusion pumps in healthcare settings. For instance, in June 2023, B. Braun Medical Inc., a US-based medical device manufacturing company launched the DoseTrac Enterprise Infusion Management Software. This advanced software provides healthcare organizations with real-time views and retrospective reporting features, allowing them to effectively manage their infusion pump fleets and associated data. The platform boasts the capability to seamlessly connect up to 40,000 pumps across multiple facilities through a single application, facilitating centralized management regardless of fleet size or the number of locations. DoseTrac Enterprise aims to enhance data management, potentially reducing the clinical IT infrastructure required for infusion pumps.

What Are Latest Mergers And Acquisitions In The Infusion Pump Market?

In November 2024, ICU Medical, Inc., a US–based medical equipment manufacturing company, partnered with Otsuka Pharmaceutical Factory, Inc. to strengthen the development and supply of infusion therapy products. With this partnership, ICU Medical and Otsuka aim to expand manufacturing capacity for infusion systems, enhance supply chain stability for critical infusion equipment, and support long-term innovation to improve the safety and efficiency of infusion delivery. Otsuka Pharmaceutical Factory, Inc. is a Japan-based healthcare company that specializes in producing high-quality intravenous solutions and related therapies.

Regional Outlook

North America was the largest region in the infusion pump market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Infusion Pump Market?

The infusion pump market consists of sales of large volume infusion pump and elastomeric infusion pump. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.